STTK (STOCKS)
Shattuck Labs, Inc. Common Stock
$7.370000
-0.120000 (-1.60%)
Prev close: $7.490000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Taylor H. Schreiber
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $678.75M
- Employees
- 44
- P/E (TTM)
- -14.72
- P/B (TTM)
- 3.57
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $1.00M |
| Nonoperating Income/Loss | $3.22M |
| Operating Expenses | $56.79M |
| Research and Development | $39.32M |
| Other Operating Expenses | $17.47M |
| Operating Income/Loss | -$55.79M |
| Income/Loss From Continuing Operations After Tax | -$52.57M |
| Income/Loss From Continuing Operations Before Tax | -$28.92M |
| Net Income/Loss | -$52.57M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$52.57M |
| Net Income/Loss Available To Common Stockholders, Basic | -$52.57M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.47 |
| Diluted Earnings Per Share | -$0.47 |
| Basic Average Shares | 205,342,683 |
| Diluted Average Shares | 205,342,683 |
| Assets | $220.67M |
| Current Assets | $213.27M |
| Cash | $208.30M |
| Other Current Assets | $4.97M |
| Noncurrent Assets | $7.39M |
| Fixed Assets | $4.51M |
| Other Non-current Assets | $2.88M |
| Liabilities | $9.53M |
| Current Liabilities | $7.73M |
| Accounts Payable | $3.94M |
| Wages | $1.54M |
| Other Current Liabilities | $2.25M |
| Noncurrent Liabilities | $1.80M |
| Equity | $211.14M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $211.14M |
| Liabilities And Equity | $220.67M |
| Net Cash Flow From Operating Activities | -$41.03M |
| Net Cash Flow From Operating Activities, Continuing | -$41.03M |
| Net Cash Flow From Investing Activities | -$144.59M |
| Net Cash Flow From Investing Activities, Continuing | -$144.59M |
| Net Cash Flow From Financing Activities | $198.45M |
| Net Cash Flow From Financing Activities, Continuing | $198.45M |
| Net Cash Flow | $12.83M |
| Net Cash Flow, Continuing | $12.83M |
| Comprehensive Income/Loss | -$52.63M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$52.63M |
| Other Comprehensive Income/Loss | -$52.63M |